Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

GSK claims novel series of cathepsin K inhibitors for osteoporosis and other uses

Dec. 23, 2002

Good safety profile reported for ICA-17043 in sickle cell disease

Dec. 23, 2002

Dainippon and Kyorin sign preliminary development agreement for AS-3201

Dec. 19, 2002

Lantus: E.U. approval for flexible use, positive opinion for pediatric use

Dec. 19, 2002

Lilly's E.U. submission for ruboxistaurin delayed by phase III trial results

Dec. 19, 2002

Phase Ib/II trial of Hemospan cleared to begin in Sweden

Dec. 19, 2002

Antidiabetic pyrazolyl glycosides in Ajinomoto development pipeline

Dec. 19, 2002

Neprilysin inhibitors with utility in female arousal disorder claimed by Pfizer

Dec. 19, 2002

Third major filing for long-acting insulin analogue

Dec. 18, 2002

Results from Oxycyte animal studies

Dec. 18, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...